Mersana Therapeutics Statistics
Total Valuation
MRSN has a market cap or net worth of $40.51 million. The enterprise value is -$36.05 million.
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025, before market open.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MRSN has 124.63 million shares outstanding. The number of shares has increased by 3.10% in one year.
| Current Share Class | 124.63M |
| Shares Outstanding | 124.63M |
| Shares Change (YoY) | +3.10% |
| Shares Change (QoQ) | +0.73% |
| Owned by Insiders (%) | 1.97% |
| Owned by Institutions (%) | 48.03% |
| Float | 93.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.27 |
| Forward PS | 1.75 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.83
| Current Ratio | 1.83 |
| Quick Ratio | 1.76 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -21.07 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -30.90% |
| Return on Invested Capital (ROIC) | -173.22% |
| Return on Capital Employed (ROCE) | -141.50% |
| Revenue Per Employee | $333,392 |
| Profits Per Employee | -$725,578 |
| Employee Count | 102 |
| Asset Turnover | 0.22 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MRSN has paid $418,000 in taxes.
| Income Tax | 418,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.52% in the last 52 weeks. The beta is 0.82, so MRSN's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | -84.52% |
| 50-Day Moving Average | 0.36 |
| 200-Day Moving Average | 1.11 |
| Relative Strength Index (RSI) | 41.90 |
| Average Volume (20 Days) | 2,062,925 |
Short Selling Information
The latest short interest is 15.07 million, so 12.09% of the outstanding shares have been sold short.
| Short Interest | 15.07M |
| Short Previous Month | 11.11M |
| Short % of Shares Out | 12.09% |
| Short % of Float | 16.06% |
| Short Ratio (days to cover) | 4.92 |
Income Statement
In the last 12 months, MRSN had revenue of $34.01 million and -$74.01 million in losses. Loss per share was -$0.60.
| Revenue | 34.01M |
| Gross Profit | -38.67M |
| Operating Income | -76.85M |
| Pretax Income | -134.81M |
| Net Income | -74.01M |
| EBITDA | -75.33M |
| EBIT | -76.85M |
| Loss Per Share | -$0.60 |
Full Income StatementBalance Sheet
The company has $102.29 million in cash and $24.62 million in debt, giving a net cash position of $77.66 million or $0.62 per share.
| Cash & Cash Equivalents | 102.29M |
| Total Debt | 24.62M |
| Net Cash | 77.66M |
| Net Cash Per Share | $0.62 |
| Equity (Book Value) | -30.87M |
| Book Value Per Share | -0.25 |
| Working Capital | 48.03M |
Full Balance SheetCash Flow
| Operating Cash Flow | -79.01M |
| Capital Expenditures | n/a |
| Free Cash Flow | -79.01M |
| FCF Per Share | -$0.63 |
Full Cash Flow StatementMargins
Gross margin is -113.71%, with operating and profit margins of -225.98% and -217.64%.
| Gross Margin | -113.71% |
| Operating Margin | -225.98% |
| Pretax Margin | -216.41% |
| Profit Margin | -217.64% |
| EBITDA Margin | -221.51% |
| EBIT Margin | -225.98% |
| FCF Margin | n/a |
Dividends & Yields
MRSN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.10% |
| Shareholder Yield | -3.10% |
| Earnings Yield | -177.84% |
| FCF Yield | -189.86% |
Analyst Forecast
The average price target for MRSN is $5.75, which is 1,669.23% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.75 |
| Price Target Difference | 1,669.23% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 54.29% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MRSN has an Altman Z-Score of -11.94 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -11.94 |
| Piotroski F-Score | 3 |
